These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7827868)

  • 1. Bone marrow purging in acute lymphoblastic leukemia: biological and clinical features.
    García J; Punti C; Picon M; Tigues D; Amill B; Canals C; Ayats R; Ramon I; Gilabert R; Sierra J
    J Hematother; 1994; 3(3):203-11. PubMed ID: 7827868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
    Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
    Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: long-term follow-up.
    Mehta J; Powles R; Treleaven J; Horton C; Shepherd V; Hale G; Waldmann H; Singhal S
    Leuk Lymphoma; 1997 May; 25(5-6):479-86. PubMed ID: 9250818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia.
    Bai Y; Piao XH; Luo QL; Mao BZ
    Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
    Gilmore MJ; Hamon MD; Prentice HG; Katz F; Slaper-Cortenbach IC; Hunter AE; Gandhi L; Brenner MK; Hoffbrand AV; Mehta AB
    Bone Marrow Transplant; 1991 Jul; 8(1):19-26. PubMed ID: 1717092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia.
    Simonsson B; Burnett AK; Prentice HG; Hann IH; Brenner MK; Gibson B; Grob JP; Lönnerholm G; Morrison A; Smedmyr B
    Leukemia; 1989 Sep; 3(9):631-6. PubMed ID: 2668654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
    Gorin NC; Labopin M; Laporte JP; Douay L; Lopez M; Lesage S; Fouillard L; Isnard F; Jouet JP; Bellal N; Perot C; Van Den Akker J; Bauters F; Najman A
    Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological recovery after autologous bone marrow transplantation in acute leukemia: predictive factors.
    Canals C; Marti JM; Martinez E; Sierra J; Punti C; Granena A; Domingo A; Cubells J; Brunet S; Badell I
    J Hematother; 1993; 2(1):75-85. PubMed ID: 7921968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid.
    Vogler WR; Berdel WE; Olson AC; Winton EF; Heffner LT; Gordon DS
    Blood; 1992 Sep; 80(6):1423-9. PubMed ID: 1520869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia.
    Gonzales-Chambers R; Przepiorka D; Shadduck RK; Borochovitz D; Bloom EJ; Colvin OM; Mangan KF; Rosenfeld CS
    Med Pediatr Oncol; 1991; 19(3):160-4. PubMed ID: 2023563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
    Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
    Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of combination drug purging for autologous bone marrow transplantation.
    Rowley SD; Miller CB; Piantadosi S; Davis JM; Santos GW; Jones RJ
    J Clin Oncol; 1991 Dec; 9(12):2210-8. PubMed ID: 1960561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
    Miller CB; Rowlings PA; Zhang MJ; Jones RJ; Piantadosi S; Keating A; Armitage JO; Calderwood S; Harris RE; Klein JP; Lazarus HM; Linker CA; Sobocinski KA; Weisdorf D; Horowitz MM
    Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual leukemia and immunomagnetic bead purging in patients with BCR-ABL-positive acute lymphoblastic leukemia.
    Atta J; Martin H; Bruecher J; Elsner S; Wassmann B; Rode C; Russ A; Kvalheim G; Hoelzer D
    Bone Marrow Transplant; 1996 Sep; 18(3):541-8. PubMed ID: 8879615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth.
    Nagler A; Mumcuoglu M; Naparstek E; Or R; Gan S; Slavin S
    Leuk Res; 1993 Jan; 17(1):61-7. PubMed ID: 8429681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of 14 patients with philadelphia chromosome-positive acute lymphoblastic leukemia following autologous bone marrow transplantation in first complete remission.
    Mizuta S; Kohno A; Morishita Y; Atsuta Y; Sao H; Miyamura K; Sakamaki H; Ueda R; Morishima Y
    Int J Hematol; 2007 Feb; 85(2):140-5. PubMed ID: 17321992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.